Similar articles

Abstract: Objectives: To evaluate the inhibitory effect mediated by combination of small interfering RNAs (siRNAs) targeting different sites of hepatitis B virus (HBV) transcripts on the viral replication and antigen expression in vitro. Methods: (1) Seven siRNAs targeting surface (S), polymerase (P) or precore (PreC) region of HBV genome were designed and chemically synthesized. (2) HBV-producing HepG2.2.15 cells were treated with or without siRNAs for 72 h. (3) HBsAg and HBeAg in the cell culture medium were detected by enzyme-linked immunoadsorbent assay. (4) Intracellular viral DNA was quantified by real-time PCR (Polymerase Chain Reaction). (5) HBV viral mRNA was reverse transcribed and quantified by real-time PCR. (6) The change of cell cycle and apoptosis was determined by flow cytometry. Results: Our data demonstrated that synthetic small interfering RNAs (siRNAs) targeting S and PreC gene could efficiently and specifically inhibit HBV replication and antigen expression. The expression of HBsAg and HBeAg and the replication of HBV could be specifically inhibited in a dose-dependent manner by siRNAs. Furthermore, our results showed that the combination of siRNAs targeting various regions could inhibit HBV replication and antigen expression in a more efficient way than the use of single siRNA at the same final concentration. No apoptotic change was observed in the cell after siRNA treatment. Conclusion: Our results demonstrated that siRNAs exerted robust and specific inhibition on HBV replication and antigen expression in a cell culture system and combination of siRNAs targeting different regions exhibited more potency.

[1] Beverly, L., Davidson, P.D., 2003. Hepatic diseases-hitting the target with inhibitory RNAs. N Engl J Med, 349(24):2357-2359.

[2] Brummelkamp, T.R., Bernards, R., Agami, R., 2002. A system for stable expression of short interfering RNAs in mammalian cells. Science, 296:550-553.

[3] Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., Tuschl, T., 2001. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature, 411(6836):494-498.

[4] Fung, S.K., Lok, A.S., 2004. Management of hepatitis B patients with antiviral resistance. Antivir Ther, 9(6):1013-1026.

[5] Hamasaki, K., Nakao, K., Matsumoto, K., Ichikawa, T., Ishikawa, H., Eguchi, K., 2003. Short interfering RNA-directed inhibition of hepatitis B virus replication. FEBS Lett, 543(1-3):51-54.

[6] Hammond, S.M., Boettcher, S., Caudy, A.A., Kobayashi, R., Hannon, G.J., 2001. Argonaute2, a link between genetic and biochemical analyses of RNAi. Science, 293(5532):1146-1150.

[7] Hannon, G.J., 2002. RNA interference. Nature, 418(6894):244-251.

[8] Hilla, G., Mali, K.G., Ludmila, R., Yaakov, F., Ofer, N., Eithan, G.S., 2003. Small interfering RNA Inhibits Hepatitis B virus replication in mice. Molecular Therapy, 8(5):769-776.

[9] Jacque, J.M., Triques, K., Stevenson, M., 2002. Modulation of HIV-1 replication by RNA interference. Nature, 418(6896):435-438.

[10] Kao, J.H., Chen, D.S., 2002. Global control of hepatitis B virus infection. Lancet Infect Dis, 2(7):395-403.

[11] Kapadia, S.B., Brideau-Andersen, A., Chisari, F.V., 2003. Interference of hepatitis C virus RNA replication by short interfering RNAs. Proc Natl Acad Sci USA, 100(4):2014-2018.

[12] Lavanchy, D., 2004. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat, 11(2):1145-1153.

[13] Lee, W.M., 1997. Hepatitis B virus infection. N Engl J Med, 337(24):1733-1745.

[14] Liu, C.M., Liu, D.P., Dong, W.J., Liang, C.C., 2004. Retrovirus vector-mediated stable gene silencing in human cell. Biochem Biophys Res Commun, 313(3):716-720.

[15] Masayoshi, K., Catherine, H.W., George, Y.W., 2003. Inhibition of HBV replication by siRNA in a stable HBV-producing cell line. Hepatology, 38(4):842-850.

[16] McCaffrey, A.P., Nakai, H., Pandey, K., Huang, Z., Salazar, F.H., Xu, H., Wieland, S.F., Marion, P.L., Kay, M.A., 2003. Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol, 21(6):639-644.

[17] Plasterk, R.H.A., 2002. RNA silencing: the genome’s immune system. Science, 296(5571):1263-1265.

[18] Sells, M.A., Chen, M.L., Acs, G., 1987. Production of hepatitis B particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA, 84(4):1005-1009.

[19] Shlomai, A., Shaul, Y., 2003. Inhibition of hepatitis B virus expression and replication by RNA interference. Hepatology, 37(4):764-770.

[20] Tatsuo, K., Yuri, K., Osamu, Y., Verena, G.M., 2004. Interference of hepatitis A virus replication by small interfering RNAs. Biochemical and Biophysical Research Communications, 318(2):341-345.

[21] Turelli, P., Mangeat, B., Jost, S., Vianin, S., Trono, D., 2004. Inhibition of hepatitis B virus replication by APOBEC3G. Science, 303(5665):1829.

[22] Ying, C.X., Erik, D.C., Johan, N., 2003. Selective inhibition of hepatitis B virus replication by RNA interference. Biochemical and Biophysical Research Communications, 309(2):482-484.

[23] Zamore, P.D., 2002. Ancient pathways programmed by small RNAs. Science, 296(5571):1265-1269.

[24] Zhao, L.J., Jian, H., Zhu, H., 2003. Specific gene inhibition by adenovirus-mediated expression of small interfering RNA. Gene, 316:137-141.